New Delhi: The US Food and Drug Administration (FDA ... the US FDA said that the approval for Xolair injection was for food allergy in certain adults and children one year or older.

Xolair, or omalizumab, was granted priority review by the Food and Drug Administration on Tuesday ... to avoid foods they are ...

The approved dose is 300 mg by subcutaneous injection every four weeks. "The EU approval of Xolair in CSU is truly exciting for patients with this chronic and debilitating skin disease," said ...

Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain ...